(S1 (S (S (NP (NP (JJ Crystal) (NNS structures)) (PP (IN of) (NP (JJ human) (JJ bifunctional) (NN enzyme)))) (VP (VBP aminoimidazole-4-carboxamide) (NP (NN ribonucleotide) (NN transformylase/IMP) (NN cyclohydrolase)) (PP (IN in) (NP (NP (NN complex)) (PP (IN with) (NP (JJ potent) (JJ sulfonyl-containing) (NNS antifolates))))))) (. .)))
(S1 (S (S (NP (NP (JJ Aminoimidazole-4-carboxamide) (NN ribonucleotide) (-LRB- -LRB-) (NN AICAR) (-RRB- -RRB-) (NN transformylase/IMP) (NN cyclohydrolase)) (PRN (-LRB- -LRB-) (NP (NN ATIC)) (-RRB- -RRB-))) (VP (VBZ is) (NP (NP (DT a) (JJ bifunctional) (NN enzyme)) (PP (IN with) (NP (NP (JJ folate-dependent) (JJ AICAR) (NN transformylase)) (CC and) (NP (NN IMP) (NN cyclohydrolase) (NNS activities)))) (SBAR (WHNP (WDT that)) (S (VP (VBZ catalyzes) (NP (NP (DT the) (JJ last) (CD two) (NNS steps)) (PP (IN of) (NP (NN purine) (NN biosynthesis)))))))))) (. .)))
(S1 (S (S (NP (NP (DT The) (NN AICAR) (NN transformylase) (NNS inhibitors)) (NP (NP (NN BW1540)) (CC and) (NP (NN BW2315)))) (VP (VBP are) (NP (NP (JJ sulfamido-bridged) (NN 5,8-dideazafolate) (NNS analogs)) (PP (IN with) (NP (NP (ADJP (RB remarkably) (JJ potent)) (NN K-LRB-i-RRB-) (NNS values)) (PP (IN of) (NP (NP (QP (CD 8) (CC and) (CD 6)) (NN nm)) (, ,) (ADVP (RB respectively)) (, ,) (VP (VBN compared) (PP (IN with) (NP (JJS most) (JJ other) (NNS antifolates))))))))))) (. .)))
(S1 (S (NP (NP (JJ Crystal) (NNS structures)) (PP (IN of) (NP (NN ATIC))) (PP (IN at) (NP (NP (NP (CD 2.55)) (CC and) (NP (CD 2.60) (DT A))) (PP (IN with) (NP (DT each) (NN inhibitor)))))) (, ,) (PP (IN in) (DT the) (NN presence) (IN of) (NP (NN substrate) (NN AICAR))) (, ,) (VP (VBD revealed) (SBAR (IN that) (S (NP (DT the) (NN sulfonyl) (NNS groups)) (VP (VB dominate) (NP (NP (NN inhibitor) (NN binding)) (CC and) (NP (NN orientation))) (PP (IN through) (NP (NP (NN interaction)) (PP (IN with) (NP (DT the) (JJ proposed) (NN oxyanion) (NN hole))))))))) (. .)))
(S1 (S (S (NP (DT These) (NNS agents)) (ADVP (RB then)) (VP (VP (VBP appear) (S (VP (TO to) (VP (VB mimic) (NP (DT the) (JJ anionic) (NN transition) (NN state)))))) (CC and) (ADVP (RB now)) (VP (VBP implicate) (NP (NP (NN Asn-LRB-431'-RRB-)) (PP (IN in) (NP (DT the) (NN reaction) (NN mechanism)))) (PP (IN along) (PP (IN with) (NP (NP (ADJP (RB previously) (VBN identified)) (JJ key) (JJ catalytic) (NNS residues)) (ADJP (ADJP (JJ Lys-LRB-266-RRB-)) (CC and) (ADJP (JJ His-LRB-267-RRB-))))))))) (. .)))
(S1 (S (S (NP (NP (ADJP (ADJP (JJ Potent)) (CC and) (ADJP (JJ selective))) (NN inhibition)) (PP (IN of) (NP (DT the) (NN AICAR) (NN transformylase) (JJ active) (NN site))) (, ,) (VP (VBN compared) (PP (IN with) (NP (JJ other) (JJ folate-dependent) (NNS enzymes)))) (, ,)) (VP (MD should) (ADVP (RB therefore)) (VP (VB be) (VP (VBN pursued) (PP (IN by) (NP (NP (JJ further) (NN design)) (PP (IN of) (NP (JJ sulfonyl-containing) (NNS antifolates))))))))) (. .)))
